The proportion of participants with good or excellent rash improvement within 2 weeks, as rated by the participant · pityriasis rosea
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse events, i.e. serious enough to require withdrawal of the treatment · pityriasis rosea
1 finding from 1 review
The proportion of participants with resolution of itch within 2 weeks, as rated by the participant · pityriasis rosea
Acyclovir + calamine + cetirizine may leads to higher the proportion of participants with resolution of itch within 2… compared with calamine + cetirizine (low certainty).
1 finding from 1 review
Reduction in itch score within 2 weeks, as rated by the participant · pityriasis rosea
1 finding from 1 review
The proportion of participants with good or excellent rash improvement within 2 weeks, as rated by a medical practitioner · pityriasis rosea
The review found no eligible studies for this question.
1 finding from 1 review
Minor participant‐reported adverse events not requiring withdrawal of the treatment: Headache. · pityriasis rosea
Acyclovir + calamine + cetirizine showed no clear difference in minor participant‐reported adverse events not requiring withdrawal… compared with calamine + cetirizine (low certainty).
1 finding from 1 review
Intervention not reported
Acyclovir (B) versus trifluridine (A) · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14 days
1 finding from 1 review
no estimate extracted
7 participants
Moderate
Intervention not reported
Brivudine (B) versus acyclovir (A) · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14 days
1 finding from 1 review
no estimate extracted
7 participants
Moderate
Intervention not reported
Ganciclovir (B) versus acyclovir (A) · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14 days
1 finding from 1 review
no estimate extracted
7 participants
Low
Intervention not reported
Foscarnet (B) versus acyclovir (A) · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14 days
1 finding from 1 review
no estimate extracted
7 participants
Moderate
Intervention not reported
Topical acyclovir/vidarabine (B) versus topical acyclovir (A) · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14 days
1 finding from 1 review
no estimate extracted
7 participants
Moderate
Intervention not reported
Acyclovir (B) versus idoxuridine (A) · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14 days
1 finding from 1 review
no estimate extracted
7 participants
Moderate
Intervention not reported
Acyclovir (B) versus vidarabine (A) · trial participants with dendritic or geographic epithelial keratitis Outcomes: corneal epithelial healing at 7 and 14 days
1 finding from 1 review
no estimate extracted
7 participants
Moderate
Intervention not reported
Number of patients with premature beat: Astragaloside injection plus supportive therapy versus Acyclovir plus supportive therapy · patients with viral myocarditis
It is very uncertain whether the intervention changes number of patients with premature beat: Astragaloside injection plus… (very low certainty).
1 finding from 1 review
Intervention not reported
Occurrence of ocular involvement · Adult immunocompetent patients with herpes zoster ophthalmicus
It is very uncertain whether the intervention changes occurrence of ocular involvement (very low certainty).
1 finding from 1 review
Intervention not reported
Ocular involvement ‐ Dendritic ulcer · Adult immunocompetent patients with herpes zoster ophthalmicus
It is very uncertain whether the intervention changes ocular involvement ‐ Dendritic ulcer (very low certainty).
1 finding from 1 review
Intervention not reported
Ocular involvement ‐ Uveitis · Adult immunocompetent patients with herpes zoster ophthalmicus
It is very uncertain whether the intervention changes ocular involvement ‐ Uveitis (very low certainty).
1 finding from 1 review
Intervention not reported
Pain at week 24 (self‐reported; yes) · Adult immunocompetent patients with herpes zoster ophthalmicus
It is very uncertain whether the intervention changes pain at week 24 (self‐reported; yes) (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects ‐ Vomiting · Adult immunocompetent patients with herpes zoster ophthalmicus
It is very uncertain whether the intervention changes adverse effects ‐ Vomiting (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects ‐ Eyelid or facial oedema · Adult immunocompetent patients with herpes zoster ophthalmicus
It is very uncertain whether the intervention changes adverse effects ‐ Eyelid or facial oedema (very low certainty).
1 finding from 1 review